SCHEMBL7780396

SCHEMBL7780396

NS(=O)(=O)c1ccc(-c2n[nH]cc2-c2ccc(NC(=O)C(F)(F)F)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 11/20 0.64
CA2 P00918 11/20 0.64
CA12 O43570 8/20 0.64
CA9 Q16790 8/20 0.64
ABCC9 O60706 1/20 0.48
ABCC8 Q09428 1/20 0.48
KCNJ11 Q14654 1/20 0.48
PDK1 Q15118 1/20 0.48
PDK2 Q15119 1/20 0.48
PDK3 Q15120 1/20 0.48
KCNJ8 Q15842 1/20 0.48
PDK4 Q16654 1/20 0.48
CA7 P43166 3/20 0.47
CA14 Q9ULX7 1/20 0.47
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.43
CDK2 P24941 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
PSMD14 O00487 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7772921 0.89 CA12 (0.47) CA1CA2CA12CA9KDM4E
SCHEMBL8629421 0.86 CA12 (0.47) CA1CA2CA12CA9KMT2A
SCHEMBL7779453 0.85 CA1 (0.61) CA1CA2CA12CA9CA7
SCHEMBL16057183 0.80 CA1 (1.00) CA1CA2CA12CA9ABCC9
SCHEMBL7777526 0.80 PTGS2 (0.52) CA1CA2CA12CA9CA7
SCHEMBL7777551 0.78 CA1 (0.61) CA1CA2CA12CA9ABCC9
SCHEMBL7780654 0.78 PTGS2 (0.62)
SCHEMBL7773285 0.77 CA1 (0.60) CA1CA2CA12CA9CA7
SCHEMBL7780478 0.76 CA1 (0.66) CA1CA2CA12CA9CA7
SCHEMBL7780061 0.76 CA12 (0.56) CA1CA2CA12CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed